These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Five-year angiographic, OCT and clinical outcomes of a randomized comparison of everolimus and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds. Schukraft S; Arroyo D; Togni M; Goy JJ; Wenaweser P; Stadelmann M; Baeriswyl G; Muller O; Stauffer JC; Puricel S; Cook S Catheter Cardiovasc Interv; 2022 Feb; 99(3):523-532. PubMed ID: 34173699 [TBL] [Abstract][Full Text] [Related]
14. Comparison of neointimal coverage between everolimus-eluting stents and sirolimus-eluting stents: an optical coherence tomography substudy of the RESET (Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial). Kubo T; Akasaka T; Kozuma K; Kimura K; Kawamura M; Sumiyoshi T; Ino Y; Morino Y; Tanabe K; Kadota K; Kimura T; EuroIntervention; 2015 Sep; 11(5):564-71. PubMed ID: 26390517 [TBL] [Abstract][Full Text] [Related]
15. Drug-eluting stent implantation in patients with acute coronary syndrome - the Activity of Platelets after Inhibition and Cardiovascular Events: Optical Coherence Tomography (APICE OCT) study. Chieffo A; Buchanan GL; Parodi G; Versaci F; Bianchi RM; Valenti R; Saccà S; Mongiardo A; Span S; Migliorini A; Spaccarotella C; Reimers B; Antoniucci D; Indolfi C; Ferrari A; Maehara A; Mintz GS; Colombo A EuroIntervention; 2014 Dec; 10(8):916-23. PubMed ID: 24974806 [TBL] [Abstract][Full Text] [Related]
16. Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction: rationale and design of the randomised TROFI II study. Räber L; Onuma Y; Brugaletta S; Garcia-Garcia HM; Backx B; Iñiguez A; Okkels Jensen L; Cequier-Fillat À; Pilgrim T; Christiansen EH; Hofma SH; Suttorp M; Serruys PW; Sabaté M; Windecker S EuroIntervention; 2016 Jul; 12(4):482-9. PubMed ID: 26342471 [TBL] [Abstract][Full Text] [Related]
17. Randomized comparison of biolimus-eluting stents with biodegradable polymer versus everolimus-eluting stents with permanent polymer coatings assessed by optical coherence tomography. Tada T; Kastrati A; Byrne RA; Schuster T; Cuni R; King LA; Cassese S; Joner M; Pache J; Massberg S; Schömig A; Mehilli J Int J Cardiovasc Imaging; 2014 Mar; 30(3):495-504. PubMed ID: 24452729 [TBL] [Abstract][Full Text] [Related]
18. Comparison of zotarolimus-eluting stent and everolimus-eluting stent for vascular healing response: serial 3-month and 12-month optical coherence tomography study. Kim SJ; Lee H; Cho JM; Park CB; Kim W; Kato K; Yonetsu T; Kim CJ; Jang IK Coron Artery Dis; 2013 Aug; 24(5):431-9. PubMed ID: 23722649 [TBL] [Abstract][Full Text] [Related]
19. Comparable vascular response of a new generation sirolimus eluting stents when compared to fluoropolymer everolimus eluting stents in the porcine coronary restenosis model. Buszman PP; Michalak MJ; Pruski M; Fernandez C; Jelonek M; Janas A; Savard C; Gwiazdowska-Nowotka B; Żurakowski A; Wojakowski W; Buszman PE; Milewski K Cardiol J; 2016; 23(6):657-666. PubMed ID: 27976797 [TBL] [Abstract][Full Text] [Related]
20. Comparison of vascular responses after different types of second-generation drug-eluting stents implantation detected by optical coherence tomography. Ohtani H; Kimura S; Sugiyama T; Hishikari K; Misawa T; Mizusawa M; Hayasaka K; Yamakami Y; Kojima K; Sagawa Y; Hikita H; Ashikaga T; Takahashi A; Isobe M Int J Cardiovasc Imaging; 2017 Feb; 33(2):177-186. PubMed ID: 27761750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]